Eli Lilly’s Ozempic and Mounjaro, of which tirzepatide is the ... earlier this month with its controversial Super Bowl advert – offers compounded semaglutide. Shares in the company tumbled ...

The number of drug-related fatalities in the UK linked to diabetes and weight loss medications has risen to 82, according to new data from the Medicines and Healthcare Products Regulatory Agency ...

Eli Lilly’s Ozempic and Mounjaro, of which tirzepatide is the active ingredient ... into the public limelight earlier this month with its controversial Super Bowl advert – offers compounded ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Eli Lilly and Company (India) has launched 'Mounjaro,' a novel medication for obesity and type 2 diabetes, after receiving ...

Lilly reported earlier this month that its revenue in the latest fiscal quarter jumped 45% with its new products contributing more than $3.1 billion, driven mainly by strong demand for Mounjaro ...

In February last year, CEO David Ricks told Reuters that Lilly expects to launch Mounjaro in India as early as 2025. Mounjaro, chemically known as tirzepatide, is currently sold in the UK and ...

The makers of Mounjaro, Lilly UK, said patient safety is its “top priority”. Lilly UK stressed: “Regulatory agencies conduct extensive independent assessments of the benefits and risks of ...